James J Harding

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

B. Taylor, M. Berger, A. Drilon, 2018, Nature.

TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma.

W. Hahn, G. Getz, A. Iafrate, 2019, Cancer discovery.

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy.

D. Solit, W. Jarnagin, H. Yarmohammadi, 2024, The oncologist.

Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization

E. Ziv, C. Sofocleous, H. Yarmohammadi, 2024, Current oncology.